| Kathy Diamond, LPN | |
|
31 Norfolk Ln, Lebanon, PA 17042-7546 | |
| (717) 274-0021 | |
| Not Available |
| Full Name | Kathy Diamond |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 31 Norfolk Ln, Lebanon, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538464680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN276348 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathy Diamond, LPN 31 Norfolk Ln, Lebanon, PA 17042-7546 Ph: (717) 274-0021 | Kathy Diamond, LPN 31 Norfolk Ln, Lebanon, PA 17042-7546 Ph: (717) 274-0021 |
News Archive
Three Penn State scientists have received national honors for their pioneering research, begun more than 40 years ago, that led to the development of implant materials widely used today in human bone and joint repairs. Della Roy, Eugene W. White, and the late Jon N. Weber were among eight researchers nationwide recognized with the newly created Golden Goose award, sponsored by American Association of Universities and other educational and scientific organizations.
The cell is understood to be highly organized, with specialized areas for different functions and molecular motors shuttling components around.
A "brain pacemaker" called deep brain stimulation (DBS) remains an effective treatment for Parkinson's disease for at least three years, according to a study in the June 2010 online issue of Neurology, the medical journal of the American Academy of Neurology.
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
A new preprint research paper provides some insights into how this may be done using computational modeling. The study, which appeared on the medRxiv server, deals with the mitigation strategies that must be implemented in order to contain the virus.
› Verified 5 days ago
Mr. Daniel Bernard Enimpah, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3030 Chestnut St, Lebanon, PA 17042 Phone: 717-769-5841 Fax: 717-273-8244 | |
Mrs. Jennice Olan, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 N 10th St, Lebanon, PA 17046 Phone: 717-272-0852 | |
Elizabeth Ann Willey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3030 Chestnut St, Lebanon, PA 17042 Phone: 717-306-9181 | |
Martha Marie Earhart, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3030 Chestnut St, Lebanon, PA 17042 Phone: 717-273-8000 Fax: 717-273-8244 | |
Barbara Reeves, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 821 Chestnut St, Lebanon, PA 17042 Phone: 717-293-5104 | |
Rachel Thompson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1555 Lafayette St, Lebanon, PA 17042 Phone: 610-834-1122 | |
Kyra Roof, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 S 9th St, Lebanon, PA 17042 Phone: 717-273-5992 Fax: 717-273-5995 |